GB0405893D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0405893D0
GB0405893D0 GB0405893A GB0405893A GB0405893D0 GB 0405893 D0 GB0405893 D0 GB 0405893D0 GB 0405893 A GB0405893 A GB 0405893A GB 0405893 A GB0405893 A GB 0405893A GB 0405893 D0 GB0405893 D0 GB 0405893D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0405893A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0405893A priority Critical patent/GB0405893D0/en
Publication of GB0405893D0 publication Critical patent/GB0405893D0/en
Priority to CNA2005800152766A priority patent/CN101268078A/en
Priority to AU2005223351A priority patent/AU2005223351A1/en
Priority to RU2006132684/04A priority patent/RU2378274C2/en
Priority to EP05716291A priority patent/EP1735314A1/en
Priority to EP05718039A priority patent/EP1740590A1/en
Priority to KR1020067021438A priority patent/KR20060130744A/en
Priority to BRPI0508843-7A priority patent/BRPI0508843A/en
Priority to JP2007503306A priority patent/JP2007529464A/en
Priority to PCT/GB2005/000987 priority patent/WO2005090354A1/en
Priority to PCT/EP2005/003038 priority patent/WO2005090352A1/en
Priority to US10/598,973 priority patent/US20080275078A1/en
Priority to CA002559629A priority patent/CA2559629A1/en
Priority to US10/598,838 priority patent/US7709497B2/en
Priority to JP2007503404A priority patent/JP2007529486A/en
Priority to ARP050101028A priority patent/AR048175A1/en
Priority to TW094108054A priority patent/TW200602051A/en
Priority to PE2005000299A priority patent/PE20060078A1/en
Priority to IL178011A priority patent/IL178011A0/en
Priority to ZA200607709A priority patent/ZA200607709B/en
Priority to NO20064450A priority patent/NO20064450L/en
Priority to MA29385A priority patent/MA28531B1/en
Ceased legal-status Critical Current

Links

GB0405893A 2004-03-16 2004-03-16 Compounds Ceased GB0405893D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GB0405893A GB0405893D0 (en) 2004-03-16 2004-03-16 Compounds
JP2007503404A JP2007529486A (en) 2004-03-16 2005-03-15 Pyrazolo [3,4-b] pyridine compounds and their use as PDE4 inhibitors
PCT/EP2005/003038 WO2005090352A1 (en) 2004-03-16 2005-03-15 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
CA002559629A CA2559629A1 (en) 2004-03-16 2005-03-15 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
RU2006132684/04A RU2378274C2 (en) 2004-03-16 2005-03-15 PYRAZOLO[3,4-b]PYRIDINE COMPOUND AND USE THEREOF AS PDE4 INHIBITOR
EP05716291A EP1735314A1 (en) 2004-03-16 2005-03-15 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
EP05718039A EP1740590A1 (en) 2004-03-16 2005-03-15 PYRAZOLO [3,4- b] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS
KR1020067021438A KR20060130744A (en) 2004-03-16 2005-03-15 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
BRPI0508843-7A BRPI0508843A (en) 2004-03-16 2005-03-15 compound or salt thereof, method for preparing a compound or salt thereof, method of treatment and / or disease prophylaxis, and pharmaceutical composition
JP2007503306A JP2007529464A (en) 2004-03-16 2005-03-15 Virazolo [3,4-b] pyridine compounds and their use as PDE4 inhibitors
PCT/GB2005/000987 WO2005090354A1 (en) 2004-03-16 2005-03-15 PYRAZOLO[3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS
CNA2005800152766A CN101268078A (en) 2004-03-16 2005-03-15 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
US10/598,973 US20080275078A1 (en) 2004-03-16 2005-03-15 Pyrazolo[3,4-B] Pyridine Compounds and Their Use as Pde4 Inhibitors
AU2005223351A AU2005223351A1 (en) 2004-03-16 2005-03-15 Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
US10/598,838 US7709497B2 (en) 2004-03-16 2005-03-15 Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
PE2005000299A PE20060078A1 (en) 2004-03-16 2005-03-16 PYRAZOLO [3,4-B] PYRIDINE COMPOUND AS INHIBITOR OF TYPE IV PHOSPHODIESTERASE
ARP050101028A AR048175A1 (en) 2004-03-16 2005-03-16 PIRAZOLO COMPOUND (3,4-B) PIRIDINE AND ITS USE AS A PDE4 INHIBITOR
TW094108054A TW200602051A (en) 2004-03-16 2005-03-16 Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
IL178011A IL178011A0 (en) 2004-03-16 2006-09-11 Pyrazolo[3,4-b] pyridine compounds, and its use as a pde4 inhibitor
ZA200607709A ZA200607709B (en) 2004-03-16 2006-09-14 Pyrazolo[3, 4-B]pyridine compound, and its use as a PDE4 inhibitor
NO20064450A NO20064450L (en) 2004-03-16 2006-10-02 Pyrazolo [3,4-β] pyridine compound and its use as a PDE4 inhibitor
MA29385A MA28531B1 (en) 2004-03-16 2006-10-13 COMPOSITION OF PYRAZOLO [3,4-B] PYRIDINE, AND ITS USE AS A PDEA4 INHIBITOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0405893A GB0405893D0 (en) 2004-03-16 2004-03-16 Compounds

Publications (1)

Publication Number Publication Date
GB0405893D0 true GB0405893D0 (en) 2004-04-21

Family

ID=32117788

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0405893A Ceased GB0405893D0 (en) 2004-03-16 2004-03-16 Compounds

Country Status (3)

Country Link
CN (1) CN101268078A (en)
GB (1) GB0405893D0 (en)
ZA (1) ZA200607709B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102898432A (en) * 2011-07-29 2013-01-30 山东轩竹医药科技有限公司 Tricyclic compound
CN108976107B (en) * 2018-08-23 2021-03-23 南方医科大学 3-aryl-4-alkoxybenzylamine derivative and preparation method and application thereof

Also Published As

Publication number Publication date
CN101268078A (en) 2008-09-17
ZA200607709B (en) 2008-06-25

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
EP1737831A4 (en) Neurologically-active compounds
GB0405937D0 (en) Compounds
EP1755617A4 (en) Perfluorocarbon-soluble compounds
GB0405193D0 (en) Compounds
GB0405272D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0405101D0 (en) Compounds
GB0408772D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0405893D0 (en) Compounds
GB0406916D0 (en) Compounds
GB0403595D0 (en) Compounds
GB0404083D0 (en) Compounds
GB0405899D0 (en) Compounds
GB0403594D0 (en) Compounds
GB0403267D0 (en) Compounds
GB0403990D0 (en) Compounds
GB0403993D0 (en) Compounds
GB0403998D0 (en) Compounds
GB0404081D0 (en) Compounds
GB0404084D0 (en) Compounds
GB0400696D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)